BIOLOGIC AVAILABILITY, DETERMINANT FACTOR OF THERAPEUTIC ACTIVITY OF DRUGS. STATEMENT OF THE PROBLEM AND PHYSIOLOGICAL CONSIDERATIONS = BIODISPONIBILITE, FACTEUR DETERMINANT DE L'ACTIVITE THERAPEUTIQUE DES MEDICAMENTS. ETAT DU PROBLEME ET CONSIDERATIONS PHYSIOLOGIQUESWAGNER JG.1973; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1973; VOL. 7; NO 4; PP. 168-176; BIBL. 14REF.Serial Issue

VERFUEGBARKEITSPRUEFUNG IN VITRO-ERFORDERNIS, MOEGLICHKEITEN, GRENZEN = RECHERCHE DE LA BIODISPONIBILITE IN VITRO. EXIGENCES, POSSIBILITES, LIMITESDIBBERN HW.1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 2; PP. 76-78; ABS. ANGL.; BIBL. 50 REF.Serial Issue

Predicting Drug Disposition via Application of a Biopharmaceutics Drug Disposition Classification SystemBENET, Leslie Z.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 3, pp 162-167, issn 1742-7835, 6 p.Conference Paper

Biopharmaceutics classification by high throughput solubility assay and PAMPAOBATA, Kouki; SUGANO, Kiyohiko; MACHIDA, Minoru et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 181-185, issn 0363-9045, 5 p.Article

Dutch Society of Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 918-931, issn 0306-5251, 14 p.Conference Paper

Commercialization of biopharmaceutical and bioindustrial proteins from plants : Genetic and metabolic engineering for value-added traitsHOWARD, John A.Crop science. 2005, Vol 45, Num 2, pp 468-472, issn 0011-183X, 5 p.Article

Polymeric delivery systems for biopharmaceuticalsDINARVAND, Rassoul; DORKOOSH, Farid; HAMIDI, Mehrdad et al.Biotechnology & genetic engineering reviews. 2004, Vol 21, pp 147-181, issn 0264-8725, 35 p.Article

AKTUAL'NYE PROBLEMY BIOFARMATSII: SBORNIK NAUCHNYKH TRUDOV = PROBLEMES ACTUELS DE LA BIOPHARMACIETENTSOVAYA AI.1978; ; SUN; MOSKVA: 1 M.M.I. IM. I.M. SECHENOVA; DA. 1978; 120 P.: ILL.; 20 CM; BIBL. DISSEM.Book

PREDICTION OF SYSTEMIC AVAILABILITY FROM PLASMA-LEVEL DATA AFTER ORAL DRUG ADMINISTRATION = LA PREDICTION DE LA DISPONIBILITE GENERALE D'APRES LES DONNEES DU TAUX PLASMATIQUE APRES L'ADMINISTRATION PER OS DES MEDICAMENTSPERRIER D; GIBALDI M; BOYES RN et al.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 3; PP. 256-257; BIBL. 7 REF.Serial Issue

BIOPHARMAZIE DER INJEKTABILIA. I. INJECTABILIA MIT SOFORTWIRKUNG = BIOPHARMACIE DES PRODUITS INJECTABLES. I. PRODUITS INJECTABLES AVEC UNE ACTION IMMEDIATE1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 5; PP. 273-285; ABS. ANGL.; BIBL. 119REF.Serial Issue

SALICYLATE RELEASE CHARACTERISTICS OF SELECTED POLYETHYLENE GLYCOL SUPPOSITORIES = CARACTERISTIQUES DE LA LIBERATION DE SALICYLATES A PARTIR DE SUPPOSITOIRES EN POLYETHYLENE GLYCOLS SELECTIONNESPUFFER HW; CROWELL WJ.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 2; PP. 242-245; BIBL. 16 REF.Serial Issue

DIE ARZNEISTOFFRESSORPTION IM GASTROINTESTINALTRAKT. II. IN VITRO- UNTERSUCHUNG LIPOPHILER SUBSTANZEN = LA RESORPTION DES MEDICAMENTS DANS LE TRACTUS GASTROINTESTINAL. II. ETUDE IN VITRO DES SUBSTANCES LIPOPHILESSTRICKER H.1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 1; PP. 13-17; ABS. ANGL.; BIBL. 1REF.Serial Issue

PHYSIOLOGICAL DISPOSITION OF FENOPROFEN IN MAN. III. METABOLISM AND PROTEIN BINDING OF FENOPROFEN = DISPONIBILITE PHYSIOLOGIQUE DU FENOPROFEN CHEZ L'HOMME. III. METABOLISME ET FIXATION PROTEIQUE DU FENOPROFENRUBIN A; WARRICK P; WOLEN RL et al.1972; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1972; VOL. 183; NO 2; PP. 449-457; BIBL. 14 REF.Serial Issue

APPORT DE LA BIOPHARMACIE A LA RECHERCHE PHARMACEUTIQUE. SES DEVELOPPEMENTS A PARTIR DES THEORIES PHARMACOCINETIQUESBIEDER A; GAILLOT J.1972; FARMACO, ED. PRAT.; ITAL.; DA. 1972; VOL. 27; NO 9; PP. 471-500; BIBL. 26 REF.Serial Issue

BIOPHARMAZEUTISCHE ASPEKTE ORALER ARZNEIFORMEN = LES FORMES PHARMACEUTIQUES ORALES AU POINT DE VUE BIOPHARMACEUTIQUEROSS G; HILLER D.1974; PHARM. UNSER ZEIT; DTSCH.; DA. 1974; VOL. 3; NO 5; PP. 153-160Article

BIOLOGISCHE VERFUEGBARKEIT. BESTIMMUNG UND BEURTEILUNG = BIODISPONIBILITE. DETERMINATION ET EVALUATIONRITSCHEL WA.1973; OESTERR. APOTHEKER ZTG; OESTERR.; DA. 1973; VOL. 27; NO 4; PP. 65-72; BIBL. 23REF.Serial Issue

ZUR ABHAENGIGKEIT DES PILLENZERFALLS UND DER WIRKSTOFFFREIGABE VON DER PILLENMASSE UND ANDEREN FAKTOREN = RELATIONS ENTRE LE DELITEMENT DES PILULES ET LA LIBERATION DES PRINCIPES ACTIFS DE LA MASSE PILULAIRE ET D'AUTRES FACTEURSBOGS U; DAERR A.1973; PHARMAZIE; DTSCH.; DA. 1973; VOL. 28; NO 2; PP. 112-115; BIBL. 7REF.Serial Issue

USE OF CONFIDENCE INTERVALS IN ANALYSIS OF COMPARATIVE BIOAVAILABILITY TRIALS = L'EMPLOI DES INTERVALLES DE CONFIANCE DANS L'ANALYSE DES ESSAIS DE BIODISPONIBILITE COMPARES1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 8; PP. 1340-1341Serial Issue

BIOAVAILABILITY IN THE CLINICAL EVALUATION OF DRUGS1972; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1972; VOL. 6; NO 7; PP. 246-256; BIBL. 33 REF.Serial Issue

BIOPHARMACEUTICS AND PHARMACOKINETICSBENET LZ.1972; ANNU. REP. MEDICIN. CHEM.; U.S.A.; DA. 1972; VOL. 7; PP. 259-268; BIBL. 3P.Serial Issue

BIOPHARMACEUTICAL FACTORS INFLUENCING LD₅₀. II. PARTICLE SIZE = FACTEURS BIOPHARMACEUTIQUES INFLUANT SUR LA DL50. II. DIMENSION DES PARTICULESRITSCHEL WA; RING PE; SIEGEL EG et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 6; PP. 853-856; ABS. ALLEM.; BIBL. 12REF.Article

PHARMACOCINETIQUE ET SECURITE EN MATIERE DE MEDICAMENTDEVISSAGUET JP.1973; IN: JOURN. PHARM. INT. PARIS, SECUR. MATIERE MED.; PARIS; 1972; PARIS; SOC. ED. PHARM. SCI.; DA. 1973; PP. 75-86; BIBL. 17REF.Conference Paper

BEEINFLUSSUNG DER ARZNEIMITTELWIRKUNG DURCH DIE ARZNEIFORM = INFLUENCE DE LA FORME PHARMACEUTIQUE SUR L'ACTIVITE DU MEDICAMENTZATHURECKY L.1972; PHARMAZIE; DTSCH.; DA. 1972; VOL. 27; NO 11; PP. 686-693; BIBL. 25REF.Serial Issue

GENERIC EQUIVALENCE: A LOOK AT THE LITERATUREFLORENCE AT.1972; INDIAN J. PHARM.; INDIA; DA. 1972; VOL. 34; NO 6; PP. 129-146; BIBL. 2 P.Serial Issue

LES POMMADES. IV.LA LIBERATION ET L'ABSORPTION DES SUBSTANCES MEDICAMENTEUSES A PARTIR DES EXCIPIENTS POUR POMMADES ET LES FACTEURS QUI INFLUENT SUR L'EFFICACITE THERAPEUTIQUE DES POMMADESPERTSEV YI M; BASHURA GS; SALO DP et al.1972; FARM. ZH., U.R.S.R.; S.S.S.R.; DA. 1972; VOL. 27; NO 6; PP. 15-22; BIBL. 1P.1/2Serial Issue